Does High Intraoperative Inspired Oxygen Reduce Postoperative Arterial Oxygen Saturation?

February 2, 2010 updated by: University of Utah
The purpose of this study is to determine whether breathing high levels of oxygen during surgery affects oxygen levels after surgery. The second purpose of this study is to determine whether giving positive end expiratory pressure PEEP and high oxygen together affects patients oxygen levels after surgery.

Study Overview

Detailed Description

This is a randomized, controlled, blinded trial in patients undergoing non-abdominal surgery of the effect of intraoperative increased inspired oxygen used (FiO2>0.9 vs. FiO2 = 0.3) on non-invasive oxygen saturation (pulse oximetry, SpO2) and amount of required supplemental oxygen in the post-anesthesia care unit (PACU); arterial oxygen partial pressure (PaO2) after 45 minutes in the PACU; room air SpO2 24 hours after surgery, and amount of supplemental oxygen required 24 hours after surgery. The purpose of the study is to determine whether absorption atelectasis induced by use of inspired oxygen concentrations in excess of 90% leads to a higher risk of hypoxemia, as evidenced by room air oxygen values and the need for supplemental oxygen. The objective of this study is to determine whether high inspired oxygen (>0.8), which has been demonstrated to reduce the risk of surgical site infection in patients undergoing colon surgery and other major surgical procedures has side effects that limit its use to prevent infection in lower risk operations.

There are four groups of intraoperative ventilation management in this study. Fi02 0.3 plus PEEP, Fi02 0.3 without PEEP, Fi02 greater than 0.9 plus PEEP 3 to 5 cm of water, Fi02 greater than 0.9 without PEEP.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Utah
      • Salt Lake City, Utah, United States, 84132
        • University of Utah Health Sciences Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 66 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients aged 18-70 years undergoing surgery under general endotracheal anesthesia at the University of Utah Hospital Operating Room and the Huntsman Cancer Hospital Operating room who will be admitted to the hospital for at least 24 hours after surgery

Exclusion Criteria:

  • Major (open) abdominal surgery
  • Major spine surgery
  • Craniotomy surgery
  • Surgeries where electrocautery or laser devices may be used near the airway (eg tracheostomy, oral surgery) because of the risk of fire with high inspired oxygen in these cases
  • Procedures planned for monitored anesthesia care (MAC) or regional without general anesthesia
  • Planned airway management with a laryngeal mask airway rather than an endotracheal tube
  • Procedures planned in the prone position because this increases atelectasis
  • Planned postoperative intubation
  • Planned postoperative care in the intensive care unit
  • Recent (within 3 weeks) chemotherapy because of the increased risk of pulmonary oxygen toxicity
  • History of bleomycin administration because of the increased risk of pulmonary oxygen toxicity
  • Diagnosed Obstructive Sleep Apnea with home continuous pulmonary airway pressure (CPAP) use
  • Home oxygen use
  • Preoperative room air (RA) SpO2 <90%
  • History of spontaneous pneumothorax
  • Emergency surgery
  • Pregnancy. Women of child-bearing age are routinely screened for pregnancy urine human chorionic gonadotropin, (HCG) on the morning of surgery. Patients with a positive result will be excluded from the study (and most likely will have their elective surgery cancelled).
  • Patient refusal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 1
Group 1 will receive 30% oxygen plus PEEP + 3 to 5 cm Water duration of anesthesia and surgery
FiO2 (fraction of inspired oxygen) 0.3 plus PEEP (positive end expiratory pressure) 3-5 cm water
Other Names:
  • O2
  • Dioxygen
  • Sats
  • Oxygen Saturation
  • Pulmonary ventilation rate
  • Ventilation rate
  • Breathing rates
  • positive end expiratory pressure
Active Comparator: 2
Group 2 will receive 30% oxygen without PEEP for the duration of anesthesia and surgery
FiO2 0.3 without PEEP
Other Names:
  • O2
  • Dioxygen
  • Sats
  • Oxygen Saturation
  • Pulmonary ventilation rate
  • Ventilation rate
  • Breathing rates
Active Comparator: 3
Group 3 will receive > 90% oxygen plus PEEP + 3 to 5 cm of water for the duration of anesthesia and surgery
FiO2 >0.9 with 3-5 cm water PEEP
Other Names:
  • O2
  • Dioxygen
  • Sats
  • Oxygen Saturation
  • Pulmonary ventilation rate
  • Ventilation rate
  • Breathing rates
  • positive end expiratory pressure
Active Comparator: 4
Group 4 will receive > 90% oxygen and no PEEP for the duration of anesthesia and surgery
FiO2 >0.9 without PEEP
Other Names:
  • O2
  • Dioxygen
  • Sats
  • Oxygen Saturation
  • Pulmonary ventilation rate
  • Ventilation rate
  • Breathing rates

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygen Requirement to Maintain SpO2>90%
Time Frame: 45 min after emergence (tracheal extubation)
Arterial oxygen saturation by pulse oximetry (SpO2) is measured while subject is lying quietly in the post anesthesia care unit (PACU) and breathing room air (RA). Oxygen is added 0.5 liters per min (LPM) at a time to maintain SpO2 >90%.
45 min after emergence (tracheal extubation)
Oxygen Requirement
Time Frame: 24 hours after tracheal extubation
amount of oxygen (LPM) required to maintain SpO2 >90%
24 hours after tracheal extubation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Arterial Oxygen Saturation by Pulse Oximetry "(SpO2)"
Time Frame: 45 min after tracheal extubation
SpO2 measured on room air or minimum supplemental oxygen to keep SpO2>90%
45 min after tracheal extubation
SpO2 Postoperatively
Time Frame: 24 hours after tracheal extubation
SpO2 is measured on room air or minimum oxygen required to keep SpO2>90% on the ward 24 hours after tracheal extubation.
24 hours after tracheal extubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Harriet Hopf, M.D., University of Utah

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2008

Primary Completion (Actual)

July 1, 2009

Study Completion (Actual)

July 1, 2009

Study Registration Dates

First Submitted

July 10, 2008

First Submitted That Met QC Criteria

July 14, 2008

First Posted (Estimate)

July 15, 2008

Study Record Updates

Last Update Posted (Estimate)

February 18, 2010

Last Update Submitted That Met QC Criteria

February 2, 2010

Last Verified

February 1, 2010

More Information

Terms related to this study

Other Study ID Numbers

  • 29830

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Atelectasis

Clinical Trials on FiO2 (fraction of inspired oxygen) 0.3 plus PEEP (positive end expiratory pressure) 3 -5 cm water

Subscribe